[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-detail-32327":3,"doc-seo-32327":28},{"code":4,"msg":5,"data":6},0,"success",{"doc_id":7,"user_id":8,"nickname":9,"user_avatar":10,"doc_module":4,"category_id":11,"category_name":12,"doc_title":13,"doc_description":14,"file_id":15,"file_url":16,"file_type":17,"file_size":18,"view_count":19,"is_deleted":4,"is_public":20,"is_downloadable":20,"audit_status":20,"page_count":21,"language":22,"language_code":23,"table_of_contents":24,"faqs":25,"seo_title":13,"seo_description":14,"update_tm":26,"read_time":27},32327,16904993612988,"Olivia Brown","https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd",8,"Research & Report","Invasive and medical management approaches to non-acute myocardial ischaemic syndromes","Management strategies for non-acute myocardial ischaemic syndromes (NAMIS) remain a critical clinical topic as care for coronary artery disease has evolved through advances in PCI, CABG, pharmacological secondary prevention, anti-anginal therapy, and lifestyle intervention. Evidence from high-quality randomized controlled trials informs conversations on invasive strategy plus optimal medical therapy versus medical therapy alone. Trial findings support OMT as first-line for most patients, with PCI added for selected high-anatomical-risk or persistently symptomatic cases. For high-risk NAMIS such as multivessel disease and diabetes, CABG improves survival, while PCI benefit is less certain.","cbCaih7FwYQ52cPW","https://ap.wps.com/l/cbCaih7FwYQ52cPW","pdf",1538036,2,1,17,"English","en","# Introduction\n# Invasive versus medical management\n# Invasive therapy in high-risk subgroups\n# The evolution of OMT\n# Shared clinical decision making\n# Conclusions","[{\"question\":\"What is the main management question for non-acute myocardial ischaemic syndromes (NAMIS)?\",\"answer\":\"Whether an invasive strategy combined with optimal medical therapy (OMT) provides better outcomes than OMT alone, considering risks and benefits for shared decision making.\"},{\"question\":\"How does the evidence position OMT for most NAMIS patients?\",\"answer\":\"Randomized controlled trial evidence supports OMT as the first-line therapeutic approach for the majority of patients with NAMIS.\"},{\"question\":\"When might invasive therapy with PCI or CABG be favored?\",\"answer\":\"Selected patients with high anatomical risk or persistent anginal symptoms despite initial OMT may gain additional symptom relief from PCI. In high-risk groups such as multivessel disease and diabetes, CABG improves survival, while PCI benefit is less clear.\"}]",1781126597,43,{"code":4,"msg":29,"data":30},"ok",{"site_id":31,"language":23,"slug":32,"title":13,"keywords":33,"description":14,"schema_data":34,"social_meta":85,"head_meta":87,"extra_data":89,"updated_unix":26},105,"invasive-and-medical-management-approaches-to-non-acute-myocardial-ischaemic-syndromes","",{"@graph":35,"@context":84},[36,52,67],{"@type":37,"itemListElement":38},"BreadcrumbList",[39,43,46,49],{"item":40,"name":41,"@type":42,"position":20},"https://docshare.wps.com","Home","ListItem",{"item":44,"name":45,"@type":42,"position":19},"https://docshare.wps.com/document/","Document",{"item":47,"name":12,"@type":42,"position":48},"https://docshare.wps.com/document/research-report/",3,{"item":50,"name":13,"@type":42,"position":51},"https://docshare.wps.com/document/invasive-and-medical-management-approaches-to-non-acute-myocardial-ischaemic-syndromes/32327/",4,{"url":50,"name":13,"@type":53,"author":54,"headline":13,"publisher":56,"fileFormat":59,"description":14,"dateModified":60,"datePublished":61,"encodingFormat":59,"isAccessibleForFree":62,"interactionStatistic":63},"DigitalDocument",{"name":9,"@type":55},"Person",{"url":40,"name":57,"@type":58},"DocShare","Organization","application/pdf","2026-06-14","2026-06-10",true,{"@type":64,"interactionType":65,"userInteractionCount":19},"InteractionCounter",{"@type":66},"ViewAction",{"@type":68,"mainEntity":69},"FAQPage",[70,76,80],{"name":71,"@type":72,"acceptedAnswer":73},"What is the main management question for non-acute myocardial ischaemic syndromes (NAMIS)?","Question",{"text":74,"@type":75},"Whether an invasive strategy combined with optimal medical therapy (OMT) provides better outcomes than OMT alone, considering risks and benefits for shared decision making.","Answer",{"name":77,"@type":72,"acceptedAnswer":78},"How does the evidence position OMT for most NAMIS patients?",{"text":79,"@type":75},"Randomized controlled trial evidence supports OMT as the first-line therapeutic approach for the majority of patients with NAMIS.",{"name":81,"@type":72,"acceptedAnswer":82},"When might invasive therapy with PCI or CABG be favored?",{"text":83,"@type":75},"Selected patients with high anatomical risk or persistent anginal symptoms despite initial OMT may gain additional symptom relief from PCI. In high-risk groups such as multivessel disease and diabetes, CABG improves survival, while PCI benefit is less clear.","https://schema.org",{"og:url":50,"og:type":86,"og:title":13,"og:site_name":57,"og:description":14},"article",{"robots":88,"canonical":50},"index,follow",{"doc_id":7,"site_id":31}]